Jacobs Levy Equity Management’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$226K Sell
24,699
-96,574
-80% -$810K ﹤0.01% 904
2025
Q4
$902K Sell
121,273
-19,694
-14% -$142K ﹤0.01% 700
2025
Q3
$943K Buy
140,967
+4,605
+3% +$32K ﹤0.01% 733
2025
Q2
$903K Buy
136,362
+27,147
+25% +$193K ﹤0.01% 774
2025
Q1
$999K Sell
109,215
-62,447
-36% -$624K ﹤0.01% 811
2024
Q4
$1.8M Sell
171,662
-23,946
-12% -$283K 0.01% 610
2024
Q3
$2.34M Sell
195,608
-102,407
-34% -$885K 0.01% 571
2024
Q2
$1.71M Hold
298,015
0.01% 633
2024
Q1
$1.55M Sell
298,015
-30,814
-9% -$151K 0.01% 636
2023
Q4
$1.73M Sell
328,829
-37,354
-10% -$148K 0.01% 624
2023
Q3
$1.21M Buy
366,183
+300,450
+457% +$1.05M 0.01% 642
2023
Q2
$190K Sell
65,733
-88,687
-57% -$170K ﹤0.01% 930
2023
Q1
$165K Buy
+154,420
New +$295K ﹤0.01% 914
2022
Q1
Sell
-52,004
Closed -$754K 1002
2021
Q4
$754K Buy
+52,004
New +$739K 0.01% 782

Other funds holding BVS